Innovate GBM

Innovate GBM Rings Nasdaq Closing Bell in Honor of Brain Tumor Patients and Community 🧠🩶🔔

On Thursday, June 12, 2025, Innovate GBM had the distinct honor of ringing the Nasdaq Closing Bell at MarketSite in Times Square—commemorating not only the memory of Sanam Thukral, DVM, but also the strength of every patient, family, and advocate driving change in the fight against glioblastoma.

This moment marked a powerful milestone in our mission to transform a historically fragmented brain tumor landscape into a connected ecosystem—one that accelerates research, clinical trials, investment, and patient support.

“We are proud to ring this bell not just in memory of Sanam, but in momentum—representing every patient, every family, and every champion pushing forward a better future in the fight against GBM.”
— Kush Thukral, J.D., Co-Executive Director

Founded in Sanam’s memory, Innovate GBM unites researchers, clinicians, investors, companies, regulators, and advocates to accelerate innovation across the brain tumor space.

Innovate GBM is proud to include the advancement of veterinary neuro-oncology and comparative cancer research as part of its broader mission. UC Davis is home to one of the world’s leading veterinary medicine programs, and its work in comparative oncology offers promising insights that can benefit both human and animal patients.

To support this—and all Innovate GBM efforts to drive progress across the brain tumor ecosystem—please consider making a donation at: https://lnkd.in/grBMpF3T.

📺 Watch the recap: https://lnkd.in/gKPGjhfx
🔗 Join the movement: https://lnkd.in/grBMpF3T
🌐 Follow our journey:
📢 View our press release: https://lnkd.in/g7-ZSwTN

Sanam’s fight against glioblastoma showed us how much this community needs change.

Innovate GBM is here to build that change - connecting people, resources, and hope to rewrite the future of brain tumors.

For Sanam. For everyone like her.

We lost Sanam to GBM. But we didn’t lose her light.
Her strength now fuels a movement to ensure no one faces this fight alone.
This is for her. This is for all of us.

📢 Big News: $80M Agreement to Accelerate GBM Therapies!

🚀 OSR Holdings Inc. ($OSRH) has entered an $80 million common stock purchase agreement with White Lion GBM Innovation Fund—a major step in advancing glioblastoma treatment.

🔬 This partnership aligns with Innovate GBM’s mission to drive innovation and expand access to life-saving therapies for GBM patients. Together, we are breaking barriers and pushing for real change.

💡 Read more: https://www.prnewswire.com/news-releases/osr-holdings-inc-nasdaq-osrh-enters-into-80-million-common-stock-purchase-agreement-with-white-lion-gbm-innovation-fund-with-an-eye-towards-leveraging-innovate-gbms-non-profit-ecosystem-to-accelerate-glioblastoma-therapies-302419633.html

OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies /PRNewswire/ -- OSR Holdings, Inc. ("OSR") (NASDAQ: OSRH), a global healthcare company focused on advancing innovative therapies, today announced that it has...